Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Icahn buys Bausch Health, boosts stake in Xerox » 17:13
02/12/21
02/12
17:13
02/12/21
17:13
BHC

Bausch Health

$31.25 /

+1.14 (+3.79%)

, DAN

Dana

$22.37 /

-0.135 (-0.60%)

, IEP

Icahn Enterprises

$61.51 /

+0.64 (+1.05%)

, XRX

Xerox

$23.72 /

+0.13 (+0.55%)

, TEN

Tenneco

$10.00 /

-0.365 (-3.52%)

, LNG

Cheniere Energy

$67.52 /

-0.625 (-0.92%)

, OXY

Occidental Petroleum

$25.39 /

+0.4 (+1.60%)

, CVI

CVR Energy

$19.60 /

+0.44 (+2.30%)

, HLF

Herbalife Nutrition

$55.63 /

-0.95 (-1.68%)

Carl Icahn's Icahn…

Carl Icahn's Icahn Capital disclosed in an SEC filing its holdings as of December 31, 2020. Icahn's two new buys during the fourth quarter included, by size of position, Bausch Health (BHC) and Dana Inc. (DAN). The fund increased its stake in two holdings, namely Icahn Enterprises (IEP) and Xerox (XRX). Icahn reduced its stake two holdings, namely Tenneco Class A (TEN) and Cheniere Energy (LNG). The fund's top holdings as of December 31, in order of size, were Icahn Enterprises, Occidental Petroleum (OXY), CVR Energy (CVI), Herbalife Nutrition (HLF), and Cheniere Energy.

ShowHide Related Items >><<
XRX Xerox
$23.72 /

+0.13 (+0.55%)

TEN Tenneco
$10.00 /

-0.365 (-3.52%)

OXY Occidental Petroleum
$25.39 /

+0.4 (+1.60%)

LNG Cheniere Energy
$67.52 /

-0.625 (-0.92%)

IEP Icahn Enterprises
$61.51 /

+0.64 (+1.05%)

HLF Herbalife Nutrition
$55.63 /

-0.95 (-1.68%)

DAN Dana
$22.37 /

-0.135 (-0.60%)

CVI CVR Energy
$19.60 /

+0.44 (+2.30%)

BHC Bausch Health
$31.25 /

+1.14 (+3.79%)

BHC Bausch Health
$31.25 /

+1.14 (+3.79%)

01/22/21
Fly Intel: Top five analyst downgrades
01/22/21 Piper Sandler
Bausch Health downgraded to Neutral from Overweight at Piper Sandler
01/15/21 Jefferies
Bausch Health price target raised to $33 from $27 at Jefferies
01/13/21 Truist
Bausch Health CEO discussed inbound interest at conference, says Truist
DAN Dana
$22.37 /

-0.135 (-0.60%)

01/20/21 Deutsche Bank
Dana price target raised to $25 from $21 at Deutsche Bank
01/11/21 BofA
Dana downgraded to Neutral from Buy at BofA
12/17/20 Barclays
Dana downgraded to Equal Weight from Overweight at Barclays
12/16/20 KeyBanc
Dana price target raised to $25 from $20 at KeyBanc
IEP Icahn Enterprises
$61.51 /

+0.64 (+1.05%)

XRX Xerox
$23.72 /

+0.13 (+0.55%)

02/04/21
Fly Intel: Top five analyst downgrades
02/04/21 Morgan Stanley
Morgan Stanley cuts Xerox to Underweight, sees need to invest limiting earnings
02/04/21 Morgan Stanley
Xerox downgraded to Underweight from Equal Weight at Morgan Stanley
01/26/21 Credit Suisse
Xerox downgraded to Neutral from Outperform at Credit Suisse
TEN Tenneco
$10.00 /

-0.365 (-3.52%)

01/20/21 Deutsche Bank
Tenneco price target raised to $13 from $11 at Deutsche Bank
10/22/20 JPMorgan
Tenneco price target raised to $8 from $7 at JPMorgan
06/19/20 JPMorgan
Tenneco price target raised to $6 from $5 at JPMorgan
05/11/20 Deutsche Bank
Tenneco price target raised to $7 from $3 at Deutsche Bank
LNG Cheniere Energy
$67.52 /

-0.625 (-0.92%)

02/01/21 Scotiabank
Cheniere Energy Partners downgraded to Sector Perform from Outperform at Scotiabank
01/28/21 Wells Fargo
Cheniere Energy price target raised to $77 from $70 at Wells Fargo
01/13/21 JPMorgan
JPMorgan announces top 10 energy picks for 2021
01/11/21 Raymond James
Cheniere Energy upgraded to Strong Buy from Outperform at Raymond James
OXY Occidental Petroleum
$25.39 /

+0.4 (+1.60%)

01/21/21
Fly Intel: Top five analyst upgrades
01/21/21 Truist
Occidental Petroleum price target raised to $25 from $11 at Truist
01/21/21 Jefferies
Occidental Petroleum upgraded to Hold from Underperform at Jefferies
01/19/21 Societe Generale
Societe Generale starts Occidental at Hold after doubling of shares
CVI CVR Energy
$19.60 /

+0.44 (+2.30%)

12/16/20
Fly Intel: Top five analyst initiations
12/16/20 Raymond James
CVR Energy initiated with a Market Perform at Raymond James
12/15/20 Raymond James
CVR Energy initiated with a Market Perform at Raymond James
12/08/20 Tudor Pickering
CVR Energy upgraded to Buy from Hold at Tudor Pickering
HLF Herbalife Nutrition
$55.63 /

-0.95 (-1.68%)

12/24/20 Citi
Herbalife Nutrition price target raised to $66 from $63 at Citi
09/11/20 Jefferies
Herbalife, Nu Skin valuation gaps can close as models transform, says Jefferies
06/22/20 Citi
Citi boosts Herbalife target to $63, opens '90 Day Catalyst Watch'
05/08/20 Jefferies
Herbalife Nutrition price target raised to $45 from $40 at Jefferies
XRX Xerox
$23.72 /

+0.13 (+0.55%)

TEN Tenneco
$10.00 /

-0.365 (-3.52%)

OXY Occidental Petroleum
$25.39 /

+0.4 (+1.60%)

LNG Cheniere Energy
$67.52 /

-0.625 (-0.92%)

IEP Icahn Enterprises
$61.51 /

+0.64 (+1.05%)

HLF Herbalife Nutrition
$55.63 /

-0.95 (-1.68%)

DAN Dana
$22.37 /

-0.135 (-0.60%)

CVI CVR Energy
$19.60 /

+0.44 (+2.30%)

BHC Bausch Health
$31.25 /

+1.14 (+3.79%)

IEP Icahn Enterprises
$61.51 /

+0.64 (+1.05%)

HLF Herbalife Nutrition
$55.63 /

-0.95 (-1.68%)

XRX Xerox
$23.72 /

+0.13 (+0.55%)

TEN Tenneco
$10.00 /

-0.365 (-3.52%)

OXY Occidental Petroleum
$25.39 /

+0.4 (+1.60%)

HLF Herbalife Nutrition
$55.63 /

-0.95 (-1.68%)

BHC Bausch Health
$31.25 /

+1.14 (+3.79%)

XRX Xerox
$23.72 /

+0.13 (+0.55%)

TEN Tenneco
$10.00 /

-0.365 (-3.52%)

OXY Occidental Petroleum
$25.39 /

+0.4 (+1.60%)

LNG Cheniere Energy
$67.52 /

-0.625 (-0.92%)

HLF Herbalife Nutrition
$55.63 /

-0.95 (-1.68%)

BHC Bausch Health
$31.25 /

+1.14 (+3.79%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:54
02/04/21
02/04
09:54
02/04/21
09:54
QCOM

Qualcomm

$149.88 /

-12.45 (-7.67%)

, VIAC

ViacomCBS

$51.10 /

-0.96 (-1.84%)

, XRX

Xerox

$22.18 /

-1.39 (-5.90%)

, SPWR

SunPower

$43.07 /

-1.895 (-4.21%)

, BPY

Brookfield Property

$17.29 /

+0.08 (+0.46%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) downgraded to Neutral from Buy at Citi with analyst Christopher Danely saying he believes the 5G upside for Qualcomm "is over" and expects more instances of downside as the year progresses. 2. ViacomCBS (VIAC) downgraded to Sell from Hold at Deutsche Bank with analyst Bryan Kraft citing valuation. 3. Xerox (XRX) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Katy Huberty saying Xerox, like many hardware peers, faces a shrinking end market and a need to invest in new categories to drive long-term growth. 4. SunPower (SPWR) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Stephen Byrd sating the stock, after having outperformed solar installer and equipment stocks by 120%-200% over the last 3 months, trades at a significant premium to peers despite a lower revenue growth and EBITDA margin outlook. 5. Brookfield Property (BPY) downgraded to Sector Perform from Outperform at Scotiabank with analyst Mario Saric citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
XRX Xerox
$22.18 /

-1.39 (-5.90%)

VIAC ViacomCBS
$51.10 /

-0.96 (-1.84%)

SPWR SunPower
$43.07 /

-1.895 (-4.21%)

QCOM Qualcomm
$149.88 /

-12.45 (-7.67%)

BPY Brookfield Property
$17.29 /

+0.08 (+0.46%)

QCOM Qualcomm
$149.88 /

-12.45 (-7.67%)

02/04/21
Qualcomm price target raised to $150 from $126 at RBC Capital
02/04/21
Qualcomm results limited by Android supply constraints, says Cowen
02/04/21
Morgan Stanley trims Qualcomm target, stays Overweight after 'complicated' Q1
02/04/21
Qualcomm price target raised to $190 from $170 at Deutsche Bank
VIAC ViacomCBS
$51.10 /

-0.96 (-1.84%)

02/04/21 Deutsche Bank
ViacomCBS downgraded to Sell on valuation at Deutsche Bank
02/04/21 Wolfe Research
ViacomCBS downgraded to Peer Perform from Outperform at Wolfe Research
02/04/21 Deutsche Bank
ViacomCBS downgraded to Sell from Hold at Deutsche Bank
02/01/21
Fly Intel: Top five analyst downgrades
XRX Xerox
$22.18 /

-1.39 (-5.90%)

02/04/21 Morgan Stanley
Morgan Stanley cuts Xerox to Underweight, sees need to invest limiting earnings
02/04/21 Morgan Stanley
Xerox downgraded to Underweight from Equal Weight at Morgan Stanley
01/26/21 Credit Suisse
Xerox downgraded to Neutral from Outperform at Credit Suisse
01/19/21 Cross Research
Xerox downgraded to Sell at Cross Research on work from home headwinds
SPWR SunPower
$43.07 /

-1.895 (-4.21%)

02/04/21
SunPower downgraded to Underweight at Morgan Stanley following outperformance
02/04/21 Morgan Stanley
SunPower downgraded to Underweight from Equal Weight at Morgan Stanley
01/27/21
Fly Intel: Top five analyst downgrades
01/27/21 Piper Sandler
SunPower downgraded to Neutral from Overweight at Piper Sandler
BPY Brookfield Property
$17.29 /

+0.08 (+0.46%)

02/04/21 Scotiabank
Brookfield Property downgraded to Sector Perform on valuation at Scotiabank
02/03/21 Scotiabank
Brookfield Property downgraded to Sector Perform from Outperform at Scotiabank
01/05/21 JPMorgan
Brookfield deal 'value accretive and multiple enhancing,' says JPMorgan
11/09/20 RBC Capital
Brookfield Property downgraded to Sector Perform from Outperform at RBC Capital
XRX Xerox
$22.18 /

-1.39 (-5.90%)

VIAC ViacomCBS
$51.10 /

-0.96 (-1.84%)

SPWR SunPower
$43.07 /

-1.895 (-4.21%)

QCOM Qualcomm
$149.88 /

-12.45 (-7.67%)

BPY Brookfield Property
$17.29 /

+0.08 (+0.46%)

VIAC ViacomCBS
$51.10 /

-0.96 (-1.84%)

SPWR SunPower
$43.07 /

-1.895 (-4.21%)

QCOM Qualcomm
$149.88 /

-12.45 (-7.67%)

BPY Brookfield Property
$17.29 /

+0.08 (+0.46%)

XRX Xerox
$22.18 /

-1.39 (-5.90%)

VIAC ViacomCBS
$51.10 /

-0.96 (-1.84%)

SPWR SunPower
$43.07 /

-1.895 (-4.21%)

QCOM Qualcomm
$149.88 /

-12.45 (-7.67%)

XRX Xerox
$22.18 /

-1.39 (-5.90%)

VIAC ViacomCBS
$51.10 /

-0.96 (-1.84%)

SPWR SunPower
$43.07 /

-1.895 (-4.21%)

QCOM Qualcomm
$149.88 /

-12.45 (-7.67%)

BPY Brookfield Property
$17.29 /

+0.08 (+0.46%)

Downgrade
Morgan Stanley cuts Xerox to Underweight, sees need to invest limiting earnings » 08:01
02/04/21
02/04
08:01
02/04/21
08:01
XRX

Xerox

$23.57 /

+0.73 (+3.20%)

As previously reported,…

As previously reported, Morgan Stanley analyst Katy Huberty downgraded Xerox to Underweight from Equal Weight with a price target of $18, down from $20. Xerox, like many hardware peers, faces a shrinking end market and a need to invest in new categories to drive long-term growth, argues Huberty, who thinks making long-term investments would depress earnings and likely limit share price upside. Given the "conundrum" faced by Xerox, she believes the stock should trade in-line with "more challenged" enterprise hardware peers, Huberty said.

ShowHide Related Items >><<
XRX Xerox
$23.57 /

+0.73 (+3.20%)

XRX Xerox
$23.57 /

+0.73 (+3.20%)

02/04/21 Morgan Stanley
Xerox downgraded to Underweight from Equal Weight at Morgan Stanley
01/26/21 Credit Suisse
Xerox downgraded to Neutral from Outperform at Credit Suisse
01/19/21 Cross Research
Xerox downgraded to Sell at Cross Research on work from home headwinds
01/19/21 Cross Research
Xerox downgraded to Sell from Hold at Cross Research
XRX Xerox
$23.57 /

+0.73 (+3.20%)

XRX Xerox
$23.57 /

+0.73 (+3.20%)

XRX Xerox
$23.57 /

+0.73 (+3.20%)

Downgrade
Xerox downgraded to Underweight from Equal Weight at Morgan Stanley » 06:26
02/04/21
02/04
06:26
02/04/21
06:26
XRX

Xerox

$23.57 /

+0.73 (+3.20%)

Morgan Stanley analyst…

Morgan Stanley analyst Katy Huberty downgraded Xerox to Underweight from Equal Weight with an $18 price target.

ShowHide Related Items >><<
XRX Xerox
$23.57 /

+0.73 (+3.20%)

XRX Xerox
$23.57 /

+0.73 (+3.20%)

01/26/21 Credit Suisse
Xerox downgraded to Neutral from Outperform at Credit Suisse
01/19/21 Cross Research
Xerox downgraded to Sell at Cross Research on work from home headwinds
01/19/21 Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
XRX Xerox
$23.57 /

+0.73 (+3.20%)

XRX Xerox
$23.57 /

+0.73 (+3.20%)

XRX Xerox
$23.57 /

+0.73 (+3.20%)

Hot Stocks
Xerox creates Software, Financing, and Innovation businesses » 12:02
02/01/21
02/01
12:02
02/01/21
12:02
XRX

Xerox

$22.45 /

+1.4 (+6.65%)

Xerox announced…

Xerox announced organizational changes to support plans to create three new businesses - Software, Financing and Innovation - aimed at delivering long-term growth in 2021 and beyond. Nicole Torraco has been promoted to senior vice president, Xerox Financial Services, to lead Xerox's financing business, reporting directly to Visentin. Torraco previously served as chief strategy and M&A officer. Sam Waicberg will lead the Software business as vice president and general manager of Digital Services, reporting to President and Chief Operations Officer Steve Bandrowczak. Sam joined Xerox with the recent acquisition of CareAR, an augmented reality support platform company, where he was co-founder and CEO. Naresh Shanker, senior vice president and chief technology officer, will lead the PARC Innovation business. Xerox has made progress advancing new technology in recent years with products including 3D liquid metal and industrial IoT products, cleantech technology, signing clients and generating strong commercial interest. PARC will include the scientists and engineers located in Palo Alto, Calif.; Webster, N.Y.; Cary, N.C., and Toronto to create an innovation business that drives the commercialization of Xerox's developing disruptive technology. Executive Vice President Louie Pastor has been appointed chief corporate development officer and chief legal officer. In addition to overseeing Xerox's legal organization, Pastor will lead a new Corporate Development group responsible for sourcing, evaluating, and executing M&A opportunities and venture investments, including the company's recently announced $250M corporate venture capital fund.

ShowHide Related Items >><<
XRX Xerox
$22.45 /

+1.4 (+6.65%)

XRX Xerox
$22.45 /

+1.4 (+6.65%)

01/26/21 Credit Suisse
Xerox downgraded to Neutral from Outperform at Credit Suisse
01/19/21 Cross Research
Xerox downgraded to Sell at Cross Research on work from home headwinds
01/19/21 Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
XRX Xerox
$22.45 /

+1.4 (+6.65%)

XRX Xerox
$22.45 /

+1.4 (+6.65%)

XRX Xerox
$22.45 /

+1.4 (+6.65%)

Over a month ago
Hot Stocks
Xerox acquires CareAR, terms undisclosed » 09:05
01/28/21
01/28
09:05
01/28/21
09:05
XRX

Xerox

$20.87 /

-0.21 (-1.00%)

Xerox has expanded its…

Xerox has expanded its software portfolio with the acquisition of CareAR, an augmented reality support platform company that provides real-time access to expertise for customers, employees, and field workers.

ShowHide Related Items >><<
XRX Xerox
$20.87 /

-0.21 (-1.00%)

XRX Xerox
$20.87 /

-0.21 (-1.00%)

01/26/21 Credit Suisse
Xerox downgraded to Neutral from Outperform at Credit Suisse
01/19/21 Cross Research
Xerox downgraded to Sell at Cross Research on work from home headwinds
01/19/21 Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
XRX Xerox
$20.87 /

-0.21 (-1.00%)

XRX Xerox
$20.87 /

-0.21 (-1.00%)

XRX Xerox
$20.87 /

-0.21 (-1.00%)

Downgrade
Xerox downgraded to Neutral from Outperform at Credit Suisse » 16:43
01/26/21
01/26
16:43
01/26/21
16:43
XRX

Xerox

$21.08 /

+0.325 (+1.57%)

Credit Suisse analyst…

Credit Suisse analyst Matthew Cabral downgraded Xerox to Neutral from Outperform with a price target of $20, down from $23. The company reported "mixed" Q4 results as its underlying trajectory modestly improved in the early part of the quarter before momentum faded due to renewed global lockdowns in November-December, the analyst tells investors in a research note. Cabral adds that while Xerox's operating marging improved sequentially on better revenue leverage, it was still down about 5bps from last year.

ShowHide Related Items >><<
XRX Xerox
$21.08 /

+0.325 (+1.57%)

XRX Xerox
$21.08 /

+0.325 (+1.57%)

01/19/21 Cross Research
Xerox downgraded to Sell at Cross Research on work from home headwinds
01/19/21 Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
XRX Xerox
$21.08 /

+0.325 (+1.57%)

XRX Xerox
$21.08 /

+0.325 (+1.57%)

XRX Xerox
$21.08 /

+0.325 (+1.57%)

Earnings
Xerox sees FY21 revenue $7.2B, consensus $7.04B » 06:32
01/26/21
01/26
06:32
01/26/21
06:32
XRX

Xerox

$20.75 /

-0.325 (-1.54%)

Despite the high-level of…

Despite the high-level of economic uncertainty, the company expects continued progress on its strategic initiatives as projected in its 2021 financial guidance. Sees FY21 revenue of at least $7.2B in constant currency or approximately 2.5% growth. Sees FY21 operating cash flow from continuing operations of at least $600M and free cash flow of at least $500M.

ShowHide Related Items >><<
XRX Xerox
$20.75 /

-0.325 (-1.54%)

XRX Xerox
$20.75 /

-0.325 (-1.54%)

01/19/21 Cross Research
Xerox downgraded to Sell at Cross Research on work from home headwinds
01/19/21 Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
XRX Xerox
$20.75 /

-0.325 (-1.54%)

XRX Xerox
$20.75 /

-0.325 (-1.54%)

XRX Xerox
$20.75 /

-0.325 (-1.54%)

Earnings
Xerox reports Q4 adjusted EPS 58c, consensus 60c » 06:31
01/26/21
01/26
06:31
01/26/21
06:31
XRX

Xerox

$20.75 /

-0.325 (-1.54%)

Reports Q4 revenue…

Reports Q4 revenue $1.930B, consensus $1.9B. "Times of adversity require working in unison, and I couldn't be prouder of the way our team came together. We put our strategy to the test in 2020, delivering positive earnings per share and free cash flow, while returning capital to shareholders and continuing to invest in our future. The team's discipline allowed us to turn on a dime, tightly controlling expenses while steadfastly supporting clients," said Xerox Vice Chairman and CEO John Visentin. "Though the impact of the pandemic continues in 2021, we expect to return to growth this year as we increase the breadth of offerings and reach new customers in existing and new businesses."

ShowHide Related Items >><<
XRX Xerox
$20.75 /

-0.325 (-1.54%)

XRX Xerox
$20.75 /

-0.325 (-1.54%)

01/19/21 Cross Research
Xerox downgraded to Sell at Cross Research on work from home headwinds
01/19/21 Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
XRX Xerox
$20.75 /

-0.325 (-1.54%)

XRX Xerox
$20.75 /

-0.325 (-1.54%)

XRX Xerox
$20.75 /

-0.325 (-1.54%)

Downgrade
Xerox downgraded to Sell at Cross Research on work from home headwinds » 10:48
01/19/21
01/19
10:48
01/19/21
10:48
XRX

Xerox

$21.60 /

-0.89 (-3.96%)

Cross Research analyst…

Cross Research analyst Shannon Cross downgraded Xerox to Sell from Hold with a $17 price target citing expectations for continued margin pressure from work from home headwinds, stating that lock downs in Germany, the UK, France and other regions point to an even slower return to offices and prolonged pressure on page volumes. Xerox benefited in 2020 from several one-time actions that will reverse in 2021, including government assistance payments, lower royalties from Fuji Xerox, a restart of employee benefit programs and lower employee healthcare expenses, added Cross.

ShowHide Related Items >><<
XRX Xerox
$21.60 /

-0.89 (-3.96%)

XRX Xerox
$21.60 /

-0.89 (-3.96%)

01/19/21 Cross Research
Xerox downgraded to Sell from Hold at Cross Research
12/16/20 Morgan Stanley
Xerox price target raised to $24 from $17 at Morgan Stanley
10/13/20 Morgan Stanley
Morgan Stanley upgrades IT Hardware industry view to Attractive from In-Line
07/24/20
Fly Intel: Top five analyst downgrades
XRX Xerox
$21.60 /

-0.89 (-3.96%)

XRX Xerox
$21.60 /

-0.89 (-3.96%)

XRX Xerox
$21.60 /

-0.89 (-3.96%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.